Literature DB >> 29341903

Emerging roles and mechanisms of FOXC2 in cancer.

Teng Wang1, Lei Zheng1, Qian Wang1, Yan-Wei Hu2.   

Abstract

Forkhead box protein C2 (FOXC2), a transcription factor of the forkhead/winged-helix family, is required for embryonic and prenatal development. FOXC2 acts as a crucial modulator during both angiogenesis and lymphangiogenesis via multiple angiogenic and lymphangiogenic pathways, respectively. Although recent studies have shed light on the emerging role of FOXC2 in cancer, very little is known about the precise underlying mechanisms. The purpose of this review is to summarize the current understanding of FOXC2 and provide potential mechanistic explanations of the relationship between FOXC2 and cancer, as well as discuss the prospect for future research in the promising prognostic value of FOXC2 in cancer.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell proliferation; Epithelial–mesenchymal transition; FOXC2; Lymphangiogenesis; Tumor angiogenesis

Mesh:

Substances:

Year:  2018        PMID: 29341903     DOI: 10.1016/j.cca.2018.01.019

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  19 in total

1.  Homology modeling of Forkhead box protein C2: identification of potential inhibitors using ligand and structure-based virtual screening.

Authors:  Mayar Tarek Ibrahim; Jiyong Lee; Peng Tao
Journal:  Mol Divers       Date:  2022-09-01       Impact factor: 3.364

Review 2.  Forkhead Box Transcription Factors: Double-Edged Swords in Cancer.

Authors:  Maria Castaneda; Petra den Hollander; Sendurai A Mani
Journal:  Cancer Res       Date:  2022-06-06       Impact factor: 13.312

3.  Targeting Transcription Factors in Cancer: From "Undruggable" to "Druggable".

Authors:  Zhipeng Tao; Xu Wu
Journal:  Methods Mol Biol       Date:  2023

4.  The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness.

Authors:  Kristian M Hargadon; Balázs Györffy; Elijah W Strong; Brian D Tarnai; Jefferson C Thompson; David Z Bushhouse; Coleman E Johnson; Corey J Williams
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

5.  FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma.

Authors:  Jinzhang Chen; Xiaoxiang Rong; Xinhui Liu; Dayong Zheng; Xiaodong Rong; Fengsheng Chen; Peng Zhao; Feiye Liu; Jian Ruan
Journal:  Cancer Cell Int       Date:  2020-05-26       Impact factor: 5.722

6.  Meta-analysis of the likelihood of FOXC2 expression in early- and late-stage tumors.

Authors:  Tsutomu Kume; Tarek Shackour
Journal:  Oncotarget       Date:  2018-09-07

7.  Structural basis for DNA recognition by FOXC2.

Authors:  Xiaojuan Chen; Hudie Wei; Jun Li; Xujun Liang; Shuyan Dai; Longying Jiang; Ming Guo; Lingzhi Qu; Zhuchu Chen; Lin Chen; Yongheng Chen
Journal:  Nucleic Acids Res       Date:  2019-04-23       Impact factor: 16.971

8.  FOXC2 Disease Mutations Identified in Lymphedema Distichiasis Patients Impair Transcriptional Activity and Cell Proliferation.

Authors:  Daniela Tavian; Sara Missaglia; Sandro Michelini; Paolo Enrico Maltese; Elena Manara; Alvaro Mordente; Matteo Bertelli
Journal:  Int J Mol Sci       Date:  2020-07-20       Impact factor: 5.923

9.  Transcriptome Signatures of Canine Mammary Gland Tumors and Its Comparison to Human Breast Cancers.

Authors:  Kang-Hoon Lee; Hyoung-Min Park; Keun-Hong Son; Tae-Jin Shin; Je-Yoel Cho
Journal:  Cancers (Basel)       Date:  2018-09-07       Impact factor: 6.639

Review 10.  The Dominant Role of Forkhead Box Proteins in Cancer.

Authors:  Duc-Hiep Bach; Nguyen Phuoc Long; Thi-Thu-Trang Luu; Nguyen Hoang Anh; Sung Won Kwon; Sang Kook Lee
Journal:  Int J Mol Sci       Date:  2018-10-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.